GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxa5
|
ENSRNOG00000047951 | homeo box A5 |
Hoxa5
|
ENSRNOG00000006466 | homeo box A5 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxa5 | rn6_v1_chr4_-_82258765_82258765 | -0.53 | 5.2e-25 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_89151184 | 22.99 |
ENSRNOT00000010263
|
Nap1l5
|
nucleosome assembly protein 1-like 5 |
chrX_+_76083549 | 14.55 |
ENSRNOT00000003573
|
Magee1
|
MAGE family member E1 |
chr19_+_44908905 | 13.18 |
ENSRNOT00000066057
ENSRNOT00000085072 |
Cntnap4
|
contactin associated protein-like 4 |
chr3_-_25212049 | 11.80 |
ENSRNOT00000040023
|
Lrp1b
|
LDL receptor related protein 1B |
chr7_-_129970550 | 11.78 |
ENSRNOT00000055879
|
Mlc1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
chr11_+_57505005 | 11.01 |
ENSRNOT00000002942
|
LOC103693564
|
transgelin-3 |
chr1_+_151439409 | 10.96 |
ENSRNOT00000022060
ENSRNOT00000050639 |
Grm5
|
glutamate metabotropic receptor 5 |
chrX_+_25016401 | 10.73 |
ENSRNOT00000059270
|
Clcn4
|
chloride voltage-gated channel 4 |
chr9_+_9961021 | 10.68 |
ENSRNOT00000075767
|
Tubb4a
|
tubulin, beta 4A class IVa |
chr11_+_20474483 | 10.54 |
ENSRNOT00000082417
ENSRNOT00000002895 |
Ncam2
|
neural cell adhesion molecule 2 |
chr18_+_83777665 | 9.36 |
ENSRNOT00000018682
|
Cbln2
|
cerebellin 2 precursor |
chr1_-_143256591 | 9.35 |
ENSRNOT00000080925
|
Cpeb1
|
cytoplasmic polyadenylation element binding protein 1 |
chr12_+_48316143 | 8.80 |
ENSRNOT00000084511
|
Svop
|
SV2 related protein |
chr9_-_5329305 | 8.68 |
ENSRNOT00000078055
|
Slc5a7
|
solute carrier family 5 member 7 |
chr1_+_101161252 | 8.56 |
ENSRNOT00000028064
ENSRNOT00000064184 |
Slc17a7
|
solute carrier family 17 member 7 |
chrX_+_118084890 | 8.30 |
ENSRNOT00000065293
|
Htr2c
|
5-hydroxytryptamine receptor 2C |
chr13_-_49487892 | 8.28 |
ENSRNOT00000044972
|
Nfasc
|
neurofascin |
chr2_-_183210799 | 8.13 |
ENSRNOT00000085382
|
Trim2
|
tripartite motif-containing 2 |
chrX_+_151103576 | 7.89 |
ENSRNOT00000015401
|
Slitrk2
|
SLIT and NTRK-like family, member 2 |
chr2_-_227890077 | 7.75 |
ENSRNOT00000021335
|
Ndst3
|
N-deacetylase and N-sulfotransferase 3 |
chr20_+_41100071 | 7.63 |
ENSRNOT00000000658
|
Tspyl4
|
TSPY-like 4 |
chr7_+_78188912 | 7.56 |
ENSRNOT00000043079
|
Rims2
|
regulating synaptic membrane exocytosis 2 |
chr1_-_76780230 | 7.47 |
ENSRNOT00000002046
|
LOC100912485
|
alcohol sulfotransferase-like |
chr3_-_151032302 | 7.46 |
ENSRNOT00000025315
|
Ggt7
|
gamma-glutamyltransferase 7 |
chr2_+_27905535 | 7.21 |
ENSRNOT00000022120
|
Fam169a
|
family with sequence similarity 169, member A |
chr10_+_27973681 | 7.06 |
ENSRNOT00000004970
|
Gabrb2
|
gamma-aminobutyric acid type A receptor beta 2 subunit |
chr5_+_61382351 | 6.97 |
ENSRNOT00000015281
|
Aldh1b1
|
aldehyde dehydrogenase 1 family, member B1 |
chr1_-_67094567 | 6.84 |
ENSRNOT00000073583
|
AABR07071871.1
|
|
chr5_-_158549496 | 6.84 |
ENSRNOT00000074336
|
Igsf21
|
immunoglobin superfamily, member 21 |
chr8_-_96985558 | 6.81 |
ENSRNOT00000018553
|
LOC501033
|
similar to UPF0258 protein KIAA1024 |
chr13_+_6679368 | 6.75 |
ENSRNOT00000067198
ENSRNOT00000092965 |
Cntnap5c
|
contactin associated protein-like 5C |
chr2_+_115739813 | 6.47 |
ENSRNOT00000085452
|
Slc7a14
|
solute carrier family 7, member 14 |
chr3_-_52447622 | 6.41 |
ENSRNOT00000083552
|
Scn1a
|
sodium voltage-gated channel alpha subunit 1 |
chr10_+_15088935 | 6.37 |
ENSRNOT00000030273
|
Gng13
|
G protein subunit gamma 13 |
chrX_-_142248369 | 6.29 |
ENSRNOT00000091330
|
Fgf13
|
fibroblast growth factor 13 |
chr13_-_76049363 | 6.25 |
ENSRNOT00000075865
ENSRNOT00000007455 |
Brinp2
|
BMP/retinoic acid inducible neural specific 2 |
chr11_-_4397361 | 6.18 |
ENSRNOT00000046370
|
Cadm2
|
cell adhesion molecule 2 |
chr13_+_63526486 | 6.15 |
ENSRNOT00000003788
|
Brinp3
|
BMP/retinoic acid inducible neural specific 3 |
chr1_+_100393303 | 6.14 |
ENSRNOT00000026251
|
Syt3
|
synaptotagmin 3 |
chr1_-_258877045 | 6.09 |
ENSRNOT00000071633
|
Cyp2c13
|
cytochrome P450, family 2, subfamily c, polypeptide 13 |
chr3_+_35175313 | 6.06 |
ENSRNOT00000081744
|
Kif5c
|
kinesin family member 5C |
chr8_-_47094352 | 6.01 |
ENSRNOT00000048347
|
Grik4
|
glutamate ionotropic receptor kainate type subunit 4 |
chr1_-_258875572 | 6.00 |
ENSRNOT00000093005
|
Cyp2c13
|
cytochrome P450, family 2, subfamily c, polypeptide 13 |
chr1_-_211923929 | 5.98 |
ENSRNOT00000054887
|
Nkx6-2
|
NK6 homeobox 2 |
chr11_-_35099383 | 5.95 |
ENSRNOT00000066940
|
Kcnj6
|
potassium voltage-gated channel subfamily J member 6 |
chr9_+_73528681 | 5.92 |
ENSRNOT00000084340
|
Unc80
|
unc-80 homolog, NALCN activator |
chr3_-_80875817 | 5.91 |
ENSRNOT00000091265
|
Dgkz
|
diacylglycerol kinase zeta |
chr18_+_58325319 | 5.81 |
ENSRNOT00000065802
ENSRNOT00000077726 |
Napg
|
NSF attachment protein gamma |
chr10_+_82823918 | 5.75 |
ENSRNOT00000005519
|
Samd14
|
sterile alpha motif domain containing 14 |
chr1_-_148119857 | 5.72 |
ENSRNOT00000040325
|
LOC100361547
|
Cytochrome P450, family 2, subfamily c, polypeptide 7-like |
chr3_+_56862691 | 5.67 |
ENSRNOT00000087712
|
Gad1
|
glutamate decarboxylase 1 |
chr8_-_14880644 | 5.63 |
ENSRNOT00000015977
|
Fat3
|
FAT atypical cadherin 3 |
chr1_-_13915594 | 5.63 |
ENSRNOT00000015927
|
Arfgef3
|
ARFGEF family member 3 |
chr7_+_20262680 | 5.61 |
ENSRNOT00000046378
|
LOC300308
|
similar to hypothetical protein 4930509O22 |
chrX_+_23081125 | 5.60 |
ENSRNOT00000071639
|
AABR07037520.1
|
|
chr1_+_27476375 | 5.60 |
ENSRNOT00000047224
ENSRNOT00000075427 |
LOC102551716
|
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2-like |
chr12_-_23925741 | 5.56 |
ENSRNOT00000001957
|
Srrm3
|
serine/arginine repetitive matrix 3 |
chr10_-_38838272 | 5.53 |
ENSRNOT00000089495
|
Sowaha
|
sosondowah ankyrin repeat domain family member A |
chr14_+_66598259 | 5.52 |
ENSRNOT00000049743
|
Kcnip4
|
potassium voltage-gated channel interacting protein 4 |
chr15_-_76789298 | 5.49 |
ENSRNOT00000077853
|
AABR07018857.1
|
|
chr11_+_86421106 | 5.43 |
ENSRNOT00000002599
|
LOC100362453
|
serine/threonine-protein phosphatase 2A catalytic subunit alpha-like |
chr1_+_78417719 | 5.39 |
ENSRNOT00000020609
|
Tmem160
|
transmembrane protein 160 |
chr5_-_17061361 | 5.38 |
ENSRNOT00000089318
|
Penk
|
proenkephalin |
chr1_-_143256817 | 5.37 |
ENSRNOT00000078789
|
Cpeb1
|
cytoplasmic polyadenylation element binding protein 1 |
chr1_-_76517134 | 5.29 |
ENSRNOT00000064593
ENSRNOT00000085775 |
LOC100912485
|
alcohol sulfotransferase-like |
chr7_+_44009069 | 5.27 |
ENSRNOT00000005523
|
Mgat4c
|
MGAT4 family, member C |
chr1_-_215838209 | 5.21 |
ENSRNOT00000050760
|
Igf2
|
insulin-like growth factor 2 |
chr8_-_58542844 | 5.08 |
ENSRNOT00000012041
|
Elmod1
|
ELMO domain containing 1 |
chr3_-_141411170 | 4.99 |
ENSRNOT00000017364
|
Nkx2-2
|
NK2 homeobox 2 |
chr1_+_148240504 | 4.98 |
ENSRNOT00000085373
|
LOC100361547
|
Cytochrome P450, family 2, subfamily c, polypeptide 7-like |
chr4_-_168656673 | 4.90 |
ENSRNOT00000009341
|
Gpr19
|
G protein-coupled receptor 19 |
chr7_-_106695570 | 4.90 |
ENSRNOT00000083517
|
Hhla1
|
HERV-H LTR-associating 1 |
chr3_-_26056818 | 4.89 |
ENSRNOT00000044209
|
Lrp1b
|
LDL receptor related protein 1B |
chr1_-_67065797 | 4.88 |
ENSRNOT00000048152
|
Vom1r46
|
vomeronasal 1 receptor 46 |
chr4_+_154676427 | 4.87 |
ENSRNOT00000019969
ENSRNOT00000087441 |
Mug1
|
murinoglobulin 1 |
chr4_-_157266018 | 4.81 |
ENSRNOT00000019570
|
LOC100911713
|
protein C10-like |
chr1_-_67134827 | 4.78 |
ENSRNOT00000045214
|
Vom1r45
|
vomeronasal 1 receptor 45 |
chr9_-_91683468 | 4.68 |
ENSRNOT00000041550
|
Pid1
|
phosphotyrosine interaction domain containing 1 |
chr1_-_76614279 | 4.67 |
ENSRNOT00000041367
ENSRNOT00000089371 |
LOC100912485
|
alcohol sulfotransferase-like |
chr5_-_172307431 | 4.66 |
ENSRNOT00000018453
|
Fam213b
|
family with sequence similarity 213, member B |
chr1_-_195096460 | 4.61 |
ENSRNOT00000077253
|
Snrpn
|
small nuclear ribonucleoprotein polypeptide N |
chr14_+_85113578 | 4.58 |
ENSRNOT00000011158
|
Nipsnap1
|
nipsnap homolog 1 |
chr1_+_67025240 | 4.56 |
ENSRNOT00000051024
|
Vom1r47
|
vomeronasal 1 receptor 47 |
chr13_-_47397890 | 4.55 |
ENSRNOT00000005505
|
C4bpb
|
complement component 4 binding protein, beta |
chr1_-_76722965 | 4.51 |
ENSRNOT00000052129
|
LOC100912485
|
alcohol sulfotransferase-like |
chr9_-_65951516 | 4.48 |
ENSRNOT00000038132
|
Mpp4
|
membrane palmitoylated protein 4 |
chr1_+_162817611 | 4.44 |
ENSRNOT00000091952
|
Pak1
|
p21 (RAC1) activated kinase 1 |
chr8_-_76579099 | 4.43 |
ENSRNOT00000088628
|
Fam81a
|
family with sequence similarity 81, member A |
chr1_-_195096694 | 4.39 |
ENSRNOT00000088874
|
Snurf
|
SNRPN upstream reading frame |
chr5_-_13760305 | 4.38 |
ENSRNOT00000010254
|
Oprk1
|
opioid receptor, kappa 1 |
chr4_+_152630469 | 4.36 |
ENSRNOT00000013721
|
Ninj2
|
ninjurin 2 |
chr12_-_52658275 | 4.36 |
ENSRNOT00000041981
|
Zfp605
|
zinc finger protein 605 |
chr1_+_1545134 | 4.34 |
ENSRNOT00000044523
|
AABR07000156.1
|
|
chr15_+_56666012 | 4.34 |
ENSRNOT00000013408
|
Htr2a
|
5-hydroxytryptamine receptor 2A |
chr10_-_57671080 | 4.33 |
ENSRNOT00000082511
|
LOC691995
|
hypothetical protein LOC691995 |
chr16_+_54164431 | 4.27 |
ENSRNOT00000090763
|
Fgl1
|
fibrinogen-like 1 |
chr16_-_7026540 | 4.25 |
ENSRNOT00000051751
|
Itih1
|
inter-alpha trypsin inhibitor, heavy chain 1 |
chr17_+_9736577 | 4.24 |
ENSRNOT00000066586
|
F12
|
coagulation factor XII |
chr1_+_16478127 | 4.23 |
ENSRNOT00000019076
|
Ahi1
|
Abelson helper integration site 1 |
chr2_-_231409988 | 4.20 |
ENSRNOT00000080637
ENSRNOT00000037255 ENSRNOT00000074002 |
Ank2
|
ankyrin 2 |
chr17_+_81455955 | 4.19 |
ENSRNOT00000044313
|
Slc39a12
|
solute carrier family 39 member 12 |
chr1_+_53220397 | 4.16 |
ENSRNOT00000089989
|
AABR07001573.1
|
|
chr2_-_244335165 | 4.15 |
ENSRNOT00000084860
|
Rap1gds1
|
Rap1 GTPase-GDP dissociation stimulator 1 |
chr14_+_22375955 | 4.15 |
ENSRNOT00000063915
ENSRNOT00000034784 |
Ugt2b37
|
UDP-glucuronosyltransferase 2 family, member 37 |
chrX_+_106523278 | 4.14 |
ENSRNOT00000070802
|
MGC109340
|
similar to Microsomal signal peptidase 23 kDa subunit (SPase 22 kDa subunit) (SPC22/23) |
chrX_-_115764217 | 4.09 |
ENSRNOT00000009400
|
Trpc5
|
transient receptor potential cation channel, subfamily C, member 5 |
chr13_-_88061108 | 4.08 |
ENSRNOT00000003774
|
Rgs4
|
regulator of G-protein signaling 4 |
chr1_-_281756159 | 4.05 |
ENSRNOT00000013170
|
Prlhr
|
prolactin releasing hormone receptor |
chr9_+_81631409 | 4.04 |
ENSRNOT00000089580
|
Pnkd
|
paroxysmal nonkinesigenic dyskinesia |
chr7_-_71226150 | 4.00 |
ENSRNOT00000005875
|
RGD1561812
|
similar to Retinol dehydrogenase type II (RODH II) (29 k-protein) |
chr9_+_118849302 | 3.98 |
ENSRNOT00000087592
|
Dlgap1
|
DLG associated protein 1 |
chr4_+_65110746 | 3.94 |
ENSRNOT00000017675
|
Akr1d1
|
aldo-keto reductase family 1, member D1 |
chr11_-_81639872 | 3.93 |
ENSRNOT00000047595
ENSRNOT00000090031 ENSRNOT00000081864 |
Hrg
|
histidine-rich glycoprotein |
chr8_+_82043403 | 3.89 |
ENSRNOT00000091789
|
Myo5a
|
myosin VA |
chr12_+_29266602 | 3.88 |
ENSRNOT00000076194
|
Wbscr17
|
Williams-Beuren syndrome chromosome region 17 |
chr10_-_21265026 | 3.82 |
ENSRNOT00000011922
|
Tenm2
|
teneurin transmembrane protein 2 |
chrX_+_62727755 | 3.82 |
ENSRNOT00000077055
|
Pcyt1b
|
phosphate cytidylyltransferase 1, choline, beta |
chr2_+_2605996 | 3.78 |
ENSRNOT00000016372
|
Glrx
|
glutaredoxin |
chr16_-_81822716 | 3.75 |
ENSRNOT00000026677
|
F10
|
coagulation factor X |
chr2_+_72006099 | 3.71 |
ENSRNOT00000034044
|
Cdh12
|
cadherin 12 |
chr7_+_45328105 | 3.71 |
ENSRNOT00000029208
ENSRNOT00000090641 |
Slc6a15
|
solute carrier family 6 member 15 |
chr15_+_12827707 | 3.70 |
ENSRNOT00000012452
|
Fezf2
|
Fez family zinc finger 2 |
chr3_-_101474890 | 3.70 |
ENSRNOT00000091869
|
Bbox1
|
gamma-butyrobetaine hydroxylase 1 |
chr1_+_277068761 | 3.69 |
ENSRNOT00000044183
ENSRNOT00000022382 |
Habp2
|
hyaluronan binding protein 2 |
chr18_+_25749098 | 3.68 |
ENSRNOT00000027771
|
Camk4
|
calcium/calmodulin-dependent protein kinase IV |
chr18_+_54108493 | 3.66 |
ENSRNOT00000029239
|
RGD1312005
|
similar to DD1 |
chrX_+_156355376 | 3.63 |
ENSRNOT00000078304
|
Lage3
|
L antigen family, member 3 |
chr4_-_115332052 | 3.63 |
ENSRNOT00000017643
|
Clec4f
|
C-type lectin domain family 4, member F |
chr7_-_8060373 | 3.59 |
ENSRNOT00000071699
|
Olfr798
|
olfactory receptor 798 |
chr1_+_229039889 | 3.58 |
ENSRNOT00000054800
|
Glyatl1
|
glycine-N-acyltransferase-like 1 |
chr7_+_20462081 | 3.57 |
ENSRNOT00000088383
|
AABR07056131.1
|
|
chr18_+_30527705 | 3.56 |
ENSRNOT00000027168
|
Pcdhb14
|
protocadherin beta 14 |
chr7_-_2431197 | 3.55 |
ENSRNOT00000003498
|
Hsd17b6
|
hydroxysteroid (17-beta) dehydrogenase 6 |
chr8_+_98755104 | 3.55 |
ENSRNOT00000056562
|
Zic4
|
Zic family member 4 |
chr2_-_231521052 | 3.55 |
ENSRNOT00000089534
ENSRNOT00000080470 ENSRNOT00000084756 |
Ank2
|
ankyrin 2 |
chrX_+_111122552 | 3.55 |
ENSRNOT00000083566
ENSRNOT00000085078 ENSRNOT00000090928 |
Cldn2
|
claudin 2 |
chr10_-_46404642 | 3.55 |
ENSRNOT00000083698
|
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr1_-_224389389 | 3.53 |
ENSRNOT00000077408
ENSRNOT00000050010 |
UST4r
|
integral membrane transport protein UST4r |
chr10_+_1920529 | 3.52 |
ENSRNOT00000072296
|
A630010A05Rik
|
RIKEN cDNA A630010A05 gene |
chr18_+_30435119 | 3.51 |
ENSRNOT00000027190
|
Pcdhb8
|
protocadherin beta 8 |
chr1_-_67206713 | 3.49 |
ENSRNOT00000048195
|
Vom1r43
|
vomeronasal 1 receptor 43 |
chr19_+_43882249 | 3.47 |
ENSRNOT00000025761
|
Zfp1
|
zinc finger protein 1 |
chr4_+_25686392 | 3.44 |
ENSRNOT00000061199
|
Cldn12
|
claudin 12 |
chrX_+_6273733 | 3.41 |
ENSRNOT00000074275
|
Ndp
|
NDP, norrin cystine knot growth factor |
chr9_+_44491177 | 3.37 |
ENSRNOT00000075242
|
NEWGENE_1308196
|
mitochondrial ribosomal protein L30 |
chr18_+_46148849 | 3.37 |
ENSRNOT00000026724
|
Prr16
|
proline rich 16 |
chr8_-_55162421 | 3.36 |
ENSRNOT00000083102
|
Dixdc1
|
DIX domain containing 1 |
chr6_+_126434226 | 3.35 |
ENSRNOT00000090857
|
Chga
|
chromogranin A |
chr14_+_22806132 | 3.35 |
ENSRNOT00000002728
|
Ugt2b10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr1_-_233140237 | 3.34 |
ENSRNOT00000083372
|
Psat1
|
phosphoserine aminotransferase 1 |
chr1_+_107344904 | 3.33 |
ENSRNOT00000082582
|
Gas2
|
growth arrest-specific 2 |
chr10_+_103206014 | 3.33 |
ENSRNOT00000004081
|
Ttyh2
|
tweety family member 2 |
chr1_-_72129269 | 3.30 |
ENSRNOT00000049179
|
Vom1r35
|
vomeronasal 1 receptor 35 |
chr14_+_17534412 | 3.29 |
ENSRNOT00000079304
ENSRNOT00000046771 |
Cdkl2
|
cyclin dependent kinase like 2 |
chr5_-_72000318 | 3.27 |
ENSRNOT00000029187
|
AABR07048308.1
|
|
chr14_-_19132208 | 3.26 |
ENSRNOT00000060535
|
Afm
|
afamin |
chr17_-_2278613 | 3.25 |
ENSRNOT00000046525
|
Cntnap3b
|
contactin associated protein-like 3B |
chr2_-_181531978 | 3.24 |
ENSRNOT00000072029
|
Npy2r
|
neuropeptide Y receptor Y2 |
chr2_-_235831670 | 3.22 |
ENSRNOT00000037393
|
Ostc
|
oligosaccharyltransferase complex non-catalytic subunit |
chr6_-_127653124 | 3.20 |
ENSRNOT00000047324
|
Serpina11
|
serpin family A member 11 |
chr20_+_1749716 | 3.18 |
ENSRNOT00000048856
|
Olr1735
|
olfactory receptor 1735 |
chr6_+_29977797 | 3.14 |
ENSRNOT00000071784
|
Fkbp1b
|
FK506 binding protein 1B |
chr7_-_143966863 | 3.14 |
ENSRNOT00000018828
|
Sp7
|
Sp7 transcription factor |
chr7_-_130128589 | 3.12 |
ENSRNOT00000079777
ENSRNOT00000009325 |
Mapk11
|
mitogen-activated protein kinase 11 |
chr2_-_38110567 | 3.11 |
ENSRNOT00000072212
|
Ipo11
|
importin 11 |
chr3_-_127500709 | 3.11 |
ENSRNOT00000006330
|
Hao1
|
hydroxyacid oxidase 1 |
chr15_-_29369504 | 3.11 |
ENSRNOT00000060297
|
AABR07017624.1
|
|
chr6_-_132972511 | 3.07 |
ENSRNOT00000082216
|
Begain
|
brain-enriched guanylate kinase-associated |
chr5_+_115649046 | 3.07 |
ENSRNOT00000041328
|
LOC108351137
|
glyceraldehyde-3-phosphate dehydrogenase |
chr2_+_206314213 | 3.07 |
ENSRNOT00000056068
|
Bcl2l15
|
BCL2-like 15 |
chr8_-_53899669 | 3.05 |
ENSRNOT00000082257
|
Ncam1
|
neural cell adhesion molecule 1 |
chr6_+_127927650 | 3.03 |
ENSRNOT00000057271
|
LOC100909605
|
serine protease inhibitor A3F-like |
chr18_+_30550877 | 3.02 |
ENSRNOT00000027164
|
LOC108348201
|
protocadherin beta-7-like |
chr8_-_132753145 | 2.98 |
ENSRNOT00000007467
ENSRNOT00000008172 |
RGD1566368
|
similar to Solute carrier family 6 (neurotransmitter transporter), member 20 |
chr11_+_80742467 | 2.98 |
ENSRNOT00000002507
|
Masp1
|
mannan-binding lectin serine peptidase 1 |
chr1_-_221431713 | 2.93 |
ENSRNOT00000028485
|
Tm7sf2
|
transmembrane 7 superfamily member 2 |
chr13_-_88307988 | 2.93 |
ENSRNOT00000003812
|
Hsd17b7
|
hydroxysteroid (17-beta) dehydrogenase 7 |
chr9_-_65442257 | 2.93 |
ENSRNOT00000037660
|
Fam126b
|
family with sequence similarity 126, member B |
chr16_+_62153792 | 2.90 |
ENSRNOT00000074543
|
Smim18
|
small integral membrane protein 18 |
chr5_+_58995249 | 2.88 |
ENSRNOT00000023411
|
Ccdc107
|
coiled-coil domain containing 107 |
chr12_+_18679789 | 2.86 |
ENSRNOT00000001863
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9 |
chr14_-_19159923 | 2.85 |
ENSRNOT00000003879
|
Afp
|
alpha-fetoprotein |
chr5_-_63192025 | 2.85 |
ENSRNOT00000008913
|
Alg2
|
ALG2, alpha-1,3/1,6-mannosyltransferase |
chr9_+_44567206 | 2.81 |
ENSRNOT00000088544
|
NEWGENE_1308196
|
mitochondrial ribosomal protein L30 |
chr7_+_61236037 | 2.80 |
ENSRNOT00000009776
|
Il22
|
interleukin 22 |
chr14_+_99919485 | 2.79 |
ENSRNOT00000006087
|
Egfr
|
epidermal growth factor receptor |
chr2_+_257568613 | 2.79 |
ENSRNOT00000066125
|
Usp33
|
ubiquitin specific peptidase 33 |
chr10_-_109979712 | 2.79 |
ENSRNOT00000086042
|
Dus1l
|
dihydrouridine synthase 1-like |
chr4_-_183544850 | 2.78 |
ENSRNOT00000071407
|
Dennd5b
|
DENN/MADD domain containing 5B |
chr3_+_60026747 | 2.78 |
ENSRNOT00000081881
|
Scrn3
|
secernin 3 |
chr11_+_36634662 | 2.77 |
ENSRNOT00000050178
|
B3galt5
|
Beta-1,3-galactosyltransferase 5 |
chr17_-_69404323 | 2.77 |
ENSRNOT00000051342
ENSRNOT00000066282 |
Akr1c2
|
aldo-keto reductase family 1, member C2 |
chr14_-_6679878 | 2.77 |
ENSRNOT00000075989
ENSRNOT00000067875 |
Spp1
|
secreted phosphoprotein 1 |
chr4_+_70755795 | 2.77 |
ENSRNOT00000043527
|
LOC683849
|
similar to Anionic trypsin II precursor (Pretrypsinogen II) |
chr4_+_57855416 | 2.75 |
ENSRNOT00000029608
|
Cpa2
|
carboxypeptidase A2 |
chr4_-_142970245 | 2.74 |
ENSRNOT00000067815
|
AC112018.1
|
|
chr19_+_14835822 | 2.74 |
ENSRNOT00000072804
|
1700007B14Rik
|
RIKEN cDNA 1700007B14 gene |
chrX_-_82699487 | 2.72 |
ENSRNOT00000081625
|
Rps6ka6
|
ribosomal protein S6 kinase A6 |
chr3_-_8766433 | 2.72 |
ENSRNOT00000021865
|
Kyat1
|
kynurenine aminotransferase 1 |
chr4_-_117568348 | 2.71 |
ENSRNOT00000071447
|
Nat8f2
|
N-acetyltransferase 8 (GCN5-related) family member 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
2.4 | 2.4 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
2.4 | 7.2 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
2.1 | 8.6 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
2.1 | 8.3 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
1.9 | 7.7 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
1.8 | 5.4 | GO:0051867 | general adaptation syndrome, behavioral process(GO:0051867) |
1.7 | 8.7 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
1.7 | 5.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.6 | 14.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.5 | 4.5 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
1.5 | 4.4 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
1.5 | 14.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.5 | 4.4 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.4 | 4.2 | GO:0002541 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.4 | 8.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.3 | 4.0 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
1.3 | 3.9 | GO:0097037 | heme export(GO:0097037) |
1.3 | 3.8 | GO:0042441 | eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) rhodopsin metabolic process(GO:0046154) |
1.2 | 3.7 | GO:0015820 | leucine transport(GO:0015820) |
1.2 | 6.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
1.2 | 4.7 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.1 | 5.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.1 | 3.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.1 | 4.4 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
1.1 | 4.2 | GO:0039020 | pronephric nephron tubule development(GO:0039020) |
1.0 | 3.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
1.0 | 4.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.0 | 3.0 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
1.0 | 11.8 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.0 | 3.9 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
1.0 | 25.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.9 | 1.9 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.9 | 3.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.9 | 2.8 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.9 | 3.7 | GO:1904975 | response to bleomycin(GO:1904975) |
0.9 | 3.6 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.9 | 6.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.9 | 2.7 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.9 | 2.6 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.9 | 2.6 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.9 | 3.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.8 | 4.0 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.8 | 2.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.8 | 2.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.8 | 3.1 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.8 | 5.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.7 | 5.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.7 | 5.9 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.7 | 2.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.7 | 9.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.7 | 2.9 | GO:0002933 | lipid hydroxylation(GO:0002933) alkaloid catabolic process(GO:0009822) |
0.7 | 3.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.6 | 1.3 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.6 | 1.9 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.6 | 7.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.6 | 3.8 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.6 | 3.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.6 | 6.0 | GO:0071315 | cellular response to morphine(GO:0071315) |
0.6 | 2.4 | GO:0051030 | snRNA transport(GO:0051030) |
0.6 | 10.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.6 | 3.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.6 | 1.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.6 | 7.6 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.6 | 6.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.6 | 0.6 | GO:0061324 | canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) |
0.6 | 2.3 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.6 | 6.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.5 | 1.1 | GO:0009644 | response to high light intensity(GO:0009644) |
0.5 | 2.7 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.5 | 1.6 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
0.5 | 5.6 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 2.0 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.5 | 3.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.5 | 2.8 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.5 | 4.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.5 | 1.8 | GO:0019046 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
0.5 | 5.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.4 | 3.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 4.0 | GO:0098880 | maintenance of postsynaptic specialization structure(GO:0098880) maintenance of postsynaptic density structure(GO:0099562) |
0.4 | 1.7 | GO:0090118 | regulation of phosphatidylcholine catabolic process(GO:0010899) receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.4 | 3.8 | GO:1904116 | response to vasopressin(GO:1904116) |
0.4 | 4.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 7.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 1.2 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.4 | 3.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.4 | 2.8 | GO:1900019 | astrocyte activation(GO:0048143) prolactin secretion(GO:0070459) regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.4 | 1.6 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.4 | 2.4 | GO:0045901 | regulation of translational termination(GO:0006449) positive regulation of translational elongation(GO:0045901) |
0.4 | 10.5 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.4 | 1.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.4 | 1.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.4 | 2.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 2.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 1.5 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.4 | 1.1 | GO:0002397 | MHC class I protein complex assembly(GO:0002397) |
0.3 | 1.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 2.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.3 | 2.8 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 1.4 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.3 | 4.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.3 | 3.0 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 | 3.6 | GO:0051132 | NK T cell activation(GO:0051132) |
0.3 | 1.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.3 | 1.6 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.3 | 1.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 2.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 2.4 | GO:0072014 | proximal tubule development(GO:0072014) |
0.3 | 1.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 1.5 | GO:0061709 | reticulophagy(GO:0061709) |
0.3 | 0.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 3.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 0.9 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
0.3 | 6.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.3 | 0.8 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) AMP salvage(GO:0044209) adenosine biosynthetic process(GO:0046086) |
0.3 | 0.8 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.3 | 0.8 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.3 | 0.5 | GO:1903383 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
0.3 | 0.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.3 | 0.8 | GO:0000962 | mitochondrial mRNA catabolic process(GO:0000958) positive regulation of mitochondrial RNA catabolic process(GO:0000962) |
0.3 | 2.0 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.2 | 26.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 1.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 5.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 4.7 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 1.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 1.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 2.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 2.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 0.5 | GO:0034125 | negative regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034125) regulation of interleukin-4-mediated signaling pathway(GO:1902214) |
0.2 | 5.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 1.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.2 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.2 | 1.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 1.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 2.9 | GO:0042448 | ovulation from ovarian follicle(GO:0001542) progesterone metabolic process(GO:0042448) |
0.2 | 1.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 2.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 2.7 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
0.2 | 1.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 2.1 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.2 | 1.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.2 | 1.6 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.2 | 1.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 16.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.6 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.2 | 2.6 | GO:0090266 | regulation of spindle checkpoint(GO:0090231) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 2.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 1.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 0.8 | GO:0002188 | translation reinitiation(GO:0002188) |
0.2 | 6.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.6 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.2 | 0.8 | GO:1900158 | positive regulation of osteoclast proliferation(GO:0090290) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.2 | 3.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 1.8 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 0.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 1.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 0.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 0.7 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.2 | 1.8 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.2 | 1.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 1.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 1.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 0.8 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) positive regulation of female receptivity(GO:0045925) carbon catabolite activation of transcription(GO:0045991) |
0.2 | 1.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 2.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 1.0 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.2 | 1.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 0.7 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.2 | 0.5 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.5 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 4.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 12.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.2 | 1.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 3.6 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.2 | 3.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 0.8 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.2 | 0.8 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) pentose catabolic process(GO:0019323) |
0.1 | 0.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 1.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 18.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 1.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.8 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 1.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 1.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.8 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 1.8 | GO:0006063 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.1 | 0.4 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 1.0 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 2.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 2.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 2.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 | 1.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 2.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 1.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 1.2 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.5 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 5.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 1.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.3 | GO:0097198 | regulation of histone H3-K36 methylation(GO:0000414) histone H3-K36 trimethylation(GO:0097198) |
0.1 | 3.2 | GO:0051412 | response to corticosterone(GO:0051412) |
0.1 | 3.6 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 0.9 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.7 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 2.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 2.1 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.1 | 0.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.1 | 4.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.6 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.1 | 139.5 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.1 | 0.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.4 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 9.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 1.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 3.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 1.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 0.4 | GO:0010999 | regulation of eIF2 alpha phosphorylation by heme(GO:0010999) |
0.1 | 0.3 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 1.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 1.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of T-helper 1 cell differentiation(GO:0045627) response to interleukin-12(GO:0070671) |
0.1 | 2.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 1.0 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.2 | GO:0045575 | histamine metabolic process(GO:0001692) basophil activation(GO:0045575) |
0.1 | 2.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.4 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.5 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 1.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.9 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.9 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.3 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
0.1 | 2.9 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 4.6 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.2 | GO:0060266 | regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 0.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 1.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 1.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 1.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 2.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 2.7 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) negative regulation of glucokinase activity(GO:0033132) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.6 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 3.8 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 4.1 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 7.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.5 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.2 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.0 | 1.7 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 1.2 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.5 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) establishment of mitochondrion localization(GO:0051654) |
0.0 | 2.1 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 1.5 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 2.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 1.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 3.9 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.6 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 1.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.6 | GO:0000479 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 0.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.3 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.7 | GO:0072574 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) liver morphogenesis(GO:0072576) |
0.0 | 0.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 1.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.8 | GO:0031572 | mitotic G2 DNA damage checkpoint(GO:0007095) G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 1.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.4 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 1.7 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.0 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.0 | 0.1 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.0 | 0.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 1.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.0 | 1.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.9 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.4 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.5 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 1.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 1.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.5 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.0 | 1.1 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 1.0 | GO:0021766 | hippocampus development(GO:0021766) |
0.0 | 0.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 1.0 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.7 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.0 | 2.3 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.5 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 10.7 | GO:0033269 | internode region of axon(GO:0033269) |
1.7 | 8.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.3 | 3.9 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
1.0 | 6.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.0 | 14.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.9 | 3.6 | GO:0061474 | phagolysosome membrane(GO:0061474) |
0.9 | 5.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.9 | 8.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.8 | 4.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.8 | 4.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.7 | 2.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.7 | 13.0 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.6 | 11.5 | GO:0097449 | astrocyte projection(GO:0097449) |
0.6 | 1.8 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.6 | 1.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.6 | 5.6 | GO:0030891 | VCB complex(GO:0030891) |
0.5 | 2.0 | GO:0018444 | translation release factor complex(GO:0018444) |
0.5 | 2.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 6.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 7.1 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.4 | 3.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 1.9 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.4 | 4.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.4 | 2.8 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 13.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 12.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 1.9 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.3 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.3 | 6.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 4.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 3.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 17.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.3 | 2.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 0.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.3 | 1.1 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.3 | 1.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.3 | 20.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 2.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 0.8 | GO:0045025 | mitochondrial degradosome(GO:0045025) |
0.2 | 1.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 1.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.7 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.2 | 3.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 15.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 5.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 3.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.8 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.2 | 1.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 4.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 2.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 2.0 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.2 | 2.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 11.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 2.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 3.7 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 2.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 11.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 0.6 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.2 | 1.1 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 2.5 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 4.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 1.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.4 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) fumarate reductase complex(GO:0045283) |
0.1 | 2.6 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 9.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 1.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 4.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 8.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 3.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.8 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 1.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 2.2 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 1.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 1.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 2.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.9 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.6 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 2.2 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.4 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 3.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 1.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 1.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 1.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 9.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.6 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 0.7 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 1.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 2.8 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 1.5 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 8.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 2.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 8.5 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 6.4 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 7.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 1.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.8 | GO:0019013 | viral nucleocapsid(GO:0019013) |
0.0 | 3.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 2.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 1.0 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 1.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 5.0 | GO:0098793 | presynapse(GO:0098793) |
0.0 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 1.8 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 14.7 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 4.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 1.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 8.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 1.4 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 1.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.0 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:0071886 | 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding(GO:0071886) |
2.7 | 11.0 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
2.0 | 3.9 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
1.9 | 5.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
1.7 | 8.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.7 | 8.6 | GO:0015321 | inorganic phosphate transmembrane transporter activity(GO:0005315) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
1.6 | 4.9 | GO:0004556 | alpha-amylase activity(GO:0004556) |
1.4 | 5.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.3 | 7.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.2 | 6.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.1 | 5.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.1 | 14.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.0 | 5.9 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.0 | 2.9 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.0 | 2.9 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.9 | 2.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.9 | 8.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.9 | 2.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.9 | 5.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.9 | 26.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.9 | 6.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.8 | 4.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.8 | 3.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.8 | 3.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.7 | 2.2 | GO:0015563 | thiamine transmembrane transporter activity(GO:0015234) uptake transmembrane transporter activity(GO:0015563) |
0.7 | 4.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.7 | 3.6 | GO:0005534 | galactose binding(GO:0005534) |
0.7 | 2.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 2.1 | GO:0099567 | N-terminal myristoylation domain binding(GO:0031997) calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099567) |
0.6 | 3.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.6 | 3.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.6 | 6.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.6 | 2.4 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.6 | 3.6 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.6 | 1.8 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.6 | 4.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.6 | 6.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 5.5 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 1.6 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.5 | 1.5 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
0.5 | 2.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 3.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.5 | 7.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.5 | 1.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.5 | 2.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.5 | 4.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 7.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 1.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 2.6 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.4 | 3.7 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.4 | 2.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.4 | 5.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.4 | 3.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.4 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.3 | 1.4 | GO:0015265 | urea channel activity(GO:0015265) |
0.3 | 1.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 2.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 4.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.3 | 1.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.3 | 1.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 1.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 30.7 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.3 | 4.0 | GO:0098919 | structural constituent of postsynaptic specialization(GO:0098879) structural constituent of postsynaptic density(GO:0098919) |
0.3 | 4.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 3.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 9.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.3 | 0.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 0.9 | GO:0047708 | biotinidase activity(GO:0047708) |
0.3 | 4.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 0.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 2.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 3.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 1.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 1.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 5.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 1.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 1.3 | GO:0030283 | testosterone dehydrogenase [NAD(P)] activity(GO:0030283) |
0.3 | 2.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 0.8 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.3 | 2.0 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 1.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 2.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 3.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.5 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.2 | 6.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 5.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 5.8 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 3.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.2 | 1.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 3.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 1.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.2 | 5.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.6 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 2.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 1.4 | GO:0015368 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.2 | 0.6 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.2 | 1.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 1.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 1.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 2.4 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 0.7 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 18.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 2.0 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 2.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 7.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 4.6 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.8 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 0.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.4 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 55.3 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.4 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.1 | 3.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.7 | GO:0004586 | ornithine decarboxylase activity(GO:0004586) |
0.1 | 1.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 2.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 2.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 5.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.5 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 1.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 8.5 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.1 | 4.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 5.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 2.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 2.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 2.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 0.3 | GO:0000827 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) |
0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 1.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 4.0 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 3.0 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 2.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 1.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 1.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.9 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.1 | 3.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.3 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) |
0.1 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.7 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 8.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 61.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 1.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 1.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 1.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 1.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 1.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.2 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.1 | 1.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 3.5 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 2.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 3.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 3.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 3.1 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 1.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 3.8 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 3.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 1.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 1.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 12.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 3.1 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 10.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.6 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 4.6 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 1.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 5.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 3.6 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 1.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 3.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.4 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 1.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 1.7 | GO:0019842 | vitamin binding(GO:0019842) |
0.0 | 3.4 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.0 | 0.5 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 1.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 1.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 8.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.4 | GO:0032451 | demethylase activity(GO:0032451) FAD binding(GO:0071949) |
0.0 | 0.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 1.6 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 1.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 2.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 16.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 2.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 4.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 4.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 2.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 6.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 3.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 3.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 6.4 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 4.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 5.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 5.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 12.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 1.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 13.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 1.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.6 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 12.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.7 | 8.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.7 | 11.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 8.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.5 | 8.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 8.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 5.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.5 | 5.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.4 | 1.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.4 | 7.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.4 | 8.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 5.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 10.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 7.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 7.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 4.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 7.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.3 | 4.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 5.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 3.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 5.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 7.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 5.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 1.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 3.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 4.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 2.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 1.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 6.4 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.2 | 5.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 2.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 3.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 3.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 2.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 6.0 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.2 | 3.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 10.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 4.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 1.2 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 4.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 8.9 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 3.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 4.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 2.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 2.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 7.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 2.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 2.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 2.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.9 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 1.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 1.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 1.9 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 7.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 1.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.2 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |